Pyridyl substituted xanthines

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S215000, C514S268000, C514S269000, C514S270000, C514S241000, C514S263210, C514S263220

Reexamination Certificate

active

07601723

ABSTRACT:
The present invention provides compounds and pharmaceutical compositions that are substituted pyridyl-linked-xanthines of formula Iwhich are selective antagonists of A2Badenosine receptors (ARs). These compounds and compositions are useful as pharmaceutical agents.

REFERENCES:
patent: 5097097 (1992-03-01), Wang et al.
patent: 6916606 (2005-07-01), Massey et al.
patent: 7148229 (2006-12-01), Dunten et al.
patent: 2004/0192708 (2004-09-01), Dunten et al.
patent: 2007/0066631 (2007-03-01), Wang et al.
patent: 2007/0105821 (2007-05-01), Wang et al.
patent: 2007/0249598 (2007-10-01), Wang et al.
patent: WO1077110 (2001-10-01), None
Frandsen et al, Carcinogenesis, Jun. 2000; 21: 1197-1203.
Klosa, J. Prak. Chemie 22, 259-266 (1963).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Pyridyl substituted xanthines does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pyridyl substituted xanthines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyridyl substituted xanthines will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4073057

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.